Square Pharmaceuticals Limited

Square Pharmaceuticals is the flagship company of Square group which is one of the largest conglomerate in the country. The group’s turnover was over 1.56 billion US Dollar (2021) and employs over 66,000 people. Square pharmaceuticals is in manufacturing and marketing of finished pharmaceuticals products for the last 64 years. Manufacture of Active Pharmaceutical Ingredients (API) is a part of company business since in 1995. Since 1985 Square Pharma is the leader of Bangladesh Pharma market. 2020-2021 gross turnover of the company was over USD 690 Million (approx).

The company has 17 manufacturing units in 2 different sites (Dhaka Site and Pabna Site) in Bangladesh. One other manufacturing units are under construction at Dhaka site and commissioning of those units are expected to be completed by end of 2024. Solid dosage manufacturing unit has been approved by USFDA, UK MHRA, and MCC South Africa. Square’s R&D center is well equipped with State-of-the-Art analytical tools. All the products are developed in-house for filing to regulated markets.

Company’s Keywords:

manufacturing of solids, semisolids, liquid, metered dose formulaion, intravenous sterile & sterile ophthalmics, marketing, distribution